Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 14 von 17

Details

Autor(en) / Beteiligte
Titel
Assessment of the Time-tradeoff Val ues for Prophylactic Mastectomy of Women with a Suspected Genetic Predisposition to Breast Cancer
Ist Teil von
  • Medical decision making, 1998-08, Vol.18 (3), p.268-277
Ort / Verlag
Thousand Oaks, CA: Sage Publications
Erscheinungsjahr
1998
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • Background. Female carriers of the breast-cancer-susceptibility genes BRCA1 and BRCA2 are at high risk for breast cancer (85%). They face the choice between pro phylactic mastectomy (PM) and breast cancer screening. For this treatment choice, a shared-decision-making program was developed. In this program, the time tradeoff (TTO) was used to assess preferences for PM. Purpose. Assessment of the feasibility, constant proportional tradeoff, and reliability of using the TTO for this purpose. Meth ods. Fifty-four women suspected to carry the BRCA1/2 mutation were provided with comprehensive relevant information. Their preferences for PM were assessed on two occasions. Discrepancies between preferences indicated by the two tests were re solved by testing a third time. The preferences assessed on the last occasion were used for individual decision analyses. In order to test constant proportional tradeoff, the TTO consisted of four items with different numbers of life years. Results. Forty- two women (78%) completed the TTO twice and nine women (17%) performed the test a third time. Three women (5%) completed the TTO only once. The mean TTO value for PM at the last replication was 0.69 (SD = 0.30). Violations of constant pro portional tradeoff were significant: the largest tradeoffs were recorded for the shortest durations. Pearson's correlation coefficient between the TTO values for the two last sessions was 0.96. Conclusion. Assessment of individual preferences by the TTO in this patient group is feasible and reliable. Therefore, the TTO can be used in clinical settings to elicit treatment preferences of women proven or suspected to have a ge netic predisposition to breast cancer. Key words: shared decision making; breast can cer ; prophylactic mastectomy; preference assessment; time tradeoff; genetic predis position. (Med Decis Making 1998;18:268-277)
Sprache
Englisch
Identifikatoren
ISSN: 0272-989X
eISSN: 1552-681X
DOI: 10.1177/0272989X9801800303
Titel-ID: cdi_crossref_primary_10_1177_0272989X9801800303
Format

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX